Patient #41, previously classified as a high-grade myxofibrosarcoma, was reclassified as a myxoinflammatory fibroblastic sarcoma, due to amplification of the VGLL3, monosomy of chromosome 13, and the t(1;10)(p22;q24) translocation, which results in the OGA::TGFBR3 fusion gene, observed by OGM (Figure 3c) [30]. Here, OGA is linked to myxofibrosarcoma.